Enfortumab vedotin在转移性尿路细胞癌中的治疗:解决方案 最终?
Brigida Anna Maiorano1, Martina Catalano2, Evaristo Maiello1
1Oncology Unit, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Frontiers in oncology
|October 2, 2023
概括
恩福图马布维多丁 (EV) 在转移性尿路细胞癌 (mUC) 中表现有前途. 这种抗体-药物结合物向Nectin-4,改善了预先接受治疗和不符合cisplatin治疗的患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 尿癌研究 尿癌研究
背景情况:
- 转移性尿路细胞癌 (mUC) 是一个严重的临床挑战,预后不佳.
- 结核素-4在尿癌细胞上高度表达,使其成为一个可行的治疗点.
- 恩福图马布维多丁 (EV) 是一种针对内-4的抗体-药物结合体,向癌细胞提供细胞毒性有效载荷.
研究的目的:
- 审查恩福图马布维多丁 (EV) 的药理概况.
- 总结支持EV在转移性尿路细胞癌 (mUC) 的疗效的临床证据.
- 讨论EV在mUC治疗中的未来方向和潜力.
主要方法:
- 对药理性质和临床试验的文献综述.
- 从已批准的指示和正在进行的研究中分析数据.
- 综合了关于EV的作用机制和临床应用的信息.
主要成果:
- EV被批准作为预先处理的mUC的单一药物,证明了更好的反应率和存活率.
- 与 pembrolizumab 结合使用 EV 已被批准用于 cisplatin 不合格的,从未接受过治疗的 mUC 患者.
- 在有效治疗方法有限的环境中,EV提供了一种有价值的治疗选择.
结论:
- 恩福图马布维多丁 (Enfortumab vedotin) 代表了mUC疗法的重大进展.
- EV的向机制和证明的临床益处支持其在mUC管理中的作用.
- 目前正在进行的研究将进一步确定EV的最佳使用,并扩大其治疗潜力.
更多相关视频
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
14.8K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
191
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
191
01:27Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:30Urinary Tract Calculi III: Medical Management
9
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
9